Oncology R&D: emerging therapies and new challenges
The oncology market, already huge, is set for major expansion. According to analysis from GlobalData, it will generate trillions of…
The oncology market, already huge, is set for major expansion. According to analysis from GlobalData, it will generate trillions of…
Diversity in clinical trials is not merely a regulatory checkbox but a critical component of ethical and effective medical research.…
Small cell lung cancer is a fast-growing and aggressive subtype of lung cancer, accounting for approximately 10-15% of all lung…
Randomization is crucial to reduce selection bias between participants in clinical trials. eClinical data platforms should make randomization processes more…
With the world facing threats from new and emerging infectious diseases, the ability to rapidly ramp up production of essential…
The latest webinar from EMIS, a leading healthcare technology provider, showcased its Pathway platform—a robust tool designed to improve the…
Diversity in clinical trials has been the focus of numerous industry discussions in recent years. This is for good reason,…
As smaller, leaner organisations that must utilise resources carefully, biotechs face unique challenges as they enter clinical trials. These challenges…
PACE is an innovative multi-product modular automation line. This disruptive technology is making waves by creating a more agile and…
Climate change’s escalating impact is reshaping the infectious disease landscape in pervasive and profound ways. Rising temperatures are expanding the…